Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus MEDLINE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Exploring the role of NOD2 variants in pediatric undifferentiated recurrent fever: a clinical and functional perspective.

Title: Exploring the role of NOD2 variants in pediatric undifferentiated recurrent fever: a clinical and functional perspective.
Authors: Taşkın RB; Department of Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Türkiye.; Kamiloğlu AH; Department of Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Türkiye.; Bara B; Department of Medical Biology, Ege University Faculty of Medicine, Izmir, Türkiye.; Akyol G; Department of Medical Biology, Ege University Faculty of Medicine, Izmir, Türkiye.; Aydın İ; Department of Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Türkiye.; Aytac G; Department of Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Türkiye.; Karaca NE; Department of Pediatric Immunology, Ege University Faculty of Medicine, Izmir, Türkiye.; Aksu G; Department of Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Türkiye.; Department of Pediatric Immunology, Ege University Faculty of Medicine, Izmir, Türkiye.; Berdeli A; Department of Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Türkiye.; Molecular Genetics Laboratory, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Türkiye.; Bozok V; Department of Medical Biology, Ege University Faculty of Medicine, Izmir, Türkiye.; Kütükçüler N; Department of Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Türkiye.; Department of Pediatric Immunology, Ege University Faculty of Medicine, Izmir, Türkiye.
Source: Frontiers in immunology [Front Immunol] 2025 Nov 21; Vol. 16, pp. 1657782. Date of Electronic Publication: 2025 Nov 21 (Print Publication: 2025).
Publication Type: Journal Article
Language: English
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Imprint Name(s): Original Publication: [Lausanne : Frontiers Research Foundation]
MeSH Terms: Hereditary Autoinflammatory Diseases*/blood ; Hereditary Autoinflammatory Diseases*/drug therapy ; Hereditary Autoinflammatory Diseases*/genetics ; Nod2 Signaling Adaptor Protein*/genetics; Cytokines/blood ; NF-kappa B/metabolism ; Colchicine/therapeutic use ; Gout Suppressants/therapeutic use ; Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Male ; Young Adult ; Follow-Up Studies ; Longitudinal Studies ; MAP Kinase Signaling System
Abstract: Introduction: Syndrome of Undifferentiated Recurrent Fever (SURF) is an autoinflammatory disorder with onset in childhood, marked by recurrent episodes of fever without an established molecular diagnosis. Although NOD2 gene variants that are generally considered non-pathogenic are often identified in these patients, their contribution to disease development is still not well understood.; Methods: This study aimed to assess the clinical characteristics, long-term progression, and functional implications of NOD2 variants in a group of twelve children diagnosed with SURF, along with two Blau syndrome cases and two healthy controls. Clinical information was gathered at presentation and during follow-up. Peripheral blood mononuclear cells were examined for cytokine secretion and NF-kB pathway activation, both at baseline and following muramyl dipeptide stimulation, using multiplex cytokine analysis, Western blot, and ELISA.; Results: The median follow-up period was 3.75 years, with most children developing symptoms before 10 years of age. Abdominal pain and limb pain were the most frequent complaints. All patients were treated with colchicine, and selected cases required corticosteroids or disease-modifying antirheumatic drugs. Elevated levels of proinflammatory cytokines, including IL-2, TNF-a, IL- 6, and IL-8, were observed in SURF patients. Our functional studies suggested that variants like R702W, G908R, P268S/V955I, and R702W/P268S might have triggered stronger inflammatory responses, whereas L682F, L1007fs, and R587C might have been linked to diminished cytokine production and lower NF-kB activity. Certain variants, such as A1000T and P268S, appeared to show baseline NF-kB activation with moderate inflammatory activity.; Discussion: Our findings emphasize the clinical and functional diversity of NOD2 variants in SURF and may point to a possible genotype-phenotype relationship that could aid in understanding disease pathways and refining diagnostic approaches.; (Copyright © 2025 Taşkın, Kamiloğlu, Bara, Akyol, Aydın, Aytac, Karaca, Aksu, Berdeli, Bozok and Kütükçüler.)
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
References: Clin Biochem. 2008 Jul;41(10-11):920-2. (PMID: 18440310); Front Immunol. 2024 Jan 29;15:1342668. (PMID: 38348033); Rheumatology (Oxford). 2020 Feb 1;59(2):344-360. (PMID: 31325311); Clin Exp Rheumatol. 2025 Oct;43(10):1816-1822. (PMID: 40371538); Ann Rheum Dis. 2020 Nov;79(11):1492-1499. (PMID: 32647028); J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):833-840. (PMID: 32443043); Front Immunol. 2024 Sep 30;15:1433620. (PMID: 39403381); Rheumatol Int. 2019 May;39(5):911-919. (PMID: 30783801); J Exp Med. 2009 Aug 31;206(9):1883-97. (PMID: 19652016); Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101529. (PMID: 32546426); Clin Rheumatol. 2012 May;31(5):885-8. (PMID: 22234494); J Clin Immunol. 2024 Jan 17;44(2):49. (PMID: 38231350); Cancers (Basel). 2021 Oct 26;13(21):. (PMID: 34771516); Clin Exp Immunol. 2004 Dec;138(3):526-33. (PMID: 15544632); Front Genet. 2023 Jan 27;14:1065907. (PMID: 36777733); Ophthalmology. 2022 Jul;129(7):821-828. (PMID: 35314268); Arthritis Rheumatol. 2025 May;77(5):596-605. (PMID: 39622767); Autoimmunity. 2018 Mar;51(2):53-61. (PMID: 29471675); J Clin Med. 2021 May 03;10(9):. (PMID: 34063710); Trends Genet. 2023 Feb;39(2):98-108. (PMID: 36564319); Int J Rheum Dis. 2025 May;28(5):e70246. (PMID: 40329620); Int J Mol Sci. 2021 Jan 20;22(3):. (PMID: 33498296); Nat Rev Mol Cell Biol. 2021 May;22(5):346-366. (PMID: 33504982); Genet Med. 2015 May;17(5):405-24. (PMID: 25741868); Ann Rheum Dis. 2019 Aug;78(8):1025-1032. (PMID: 31018962); Genes (Basel). 2024 Jun 18;15(6):. (PMID: 38927735); RMD Open. 2015 Jul 20;1(1):e000097. (PMID: 26509073); Semin Arthritis Rheum. 2022 Aug;55:152024. (PMID: 35598507); Balkan Med J. 2020 Apr 27;37(5):236-246. (PMID: 32338845); Cytokine Growth Factor Rev. 2017 Feb;33:19-34. (PMID: 27916611); J Leukoc Biol. 2020 Jul;108(1):427-437. (PMID: 32480431); Clin Immunol. 2021 May;226:108697. (PMID: 33636366); Front Immunol. 2024 Sep 20;15:1458118. (PMID: 39372397); J Mol Neurosci. 2020 Apr;70(4):600-609. (PMID: 31907866); Front Immunol. 2022 Sep 15;13:988862. (PMID: 36189261); Cells. 2021 Aug 09;10(8):. (PMID: 34440800); J Clin Immunol. 2023 Nov;43(8):2033-2048. (PMID: 37714974); Gastroenterology. 2003 Jan;124(1):140-6. (PMID: 12512038); Respir Res. 2018 Mar 20;19(1):44. (PMID: 29554915); Gut Microbes. 2014 May-Jun;5(3):340-4. (PMID: 24637801); J Biol Chem. 2003 Feb 21;278(8):5509-12. (PMID: 12514169); FEBS Lett. 2014 Sep 17;588(18):3382-9. (PMID: 25093298); Ann Rheum Dis. 2019 Oct;78(10):1405-1411. (PMID: 31278138); Arthritis Res Ther. 2024 Feb 23;26(1):58. (PMID: 38395960)
Contributed Indexing: Keywords: NOD2; autoinflammation; autoinflammatory disease; cytokines; mutation; pediatric; recurrent fever; undifferentiated fever
Substance Nomenclature: 0 (Cytokines); 0 (NF-kappa B); 0 (NOD2 protein, human); 0 (Nod2 Signaling Adaptor Protein); SML2Y3J35T (Colchicine); 0 (Gout Suppressants)
Entry Date(s): Date Created: 20251208 Date Completed: 20251215 Latest Revision: 20251215
Update Code: 20260130
PubMed Central ID: PMC12678341
DOI: 10.3389/fimmu.2025.1657782
PMID: 41357180
Database: MEDLINE

Journal Article